Retrospective Cohort Study
Copyright ©The Author(s) 2018.
World J Clin Cases. Nov 6, 2018; 6(13): 611-623
Published online Nov 6, 2018. doi: 10.12998/wjcc.v6.i13.611
Figure 3
Figure 3 Cumulative probability of decompensation in patients with previously compensated liver disease (A) and patients with a history of hepatic decompensation (B). Patients with acute response receiving traditional NSBB are represented by a continuous line, and acute nonresponders receiving carvedilol are represented by a dashed line. P value corresponds to log-rank test at the end of follow-up. NSBB: Nonselective beta-blockers.